Cargando…
A Novel Chimeric Anti-PA Neutralizing Antibody for Postexposure Prophylaxis and Treatment of Anthrax
Anthrax is a highly lethal infectious disease caused by the bacterium Bacillus anthracis, and the associated shock is closely related to the lethal toxin (LeTx) produced by the bacterium. The central role played by the 63 kDa protective antigen (PA63) region of LeTx in the pathophysiology of anthrax...
Autores principales: | Xiong, Siping, Tang, Qi, Liang, Xudong, Zhou, Tingting, Yang, Jin, Liu, Peng, Chen, Ya, Wang, Changjun, Feng, Zhenqing, Zhu, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488766/ https://www.ncbi.nlm.nih.gov/pubmed/26134518 http://dx.doi.org/10.1038/srep11776 |
Ejemplares similares
-
Human monoclonal anti-protective antigen antibody for the low-dose post-exposure prophylaxis and treatment of Anthrax
por: Tang, Qi, et al.
Publicado: (2018) -
Anthrax Postexposure Prophylaxis in Postal Workers, Connecticut, 2001
por: Williams, Jennifer L., et al.
Publicado: (2002) -
Antimicrobial Postexposure Prophylaxis for Anthrax: Adverse Events and Adherence
por: Shepard, Colin W., et al.
Publicado: (2002) -
Screening for Anthrax Postexposure Antibiotic Prophylaxis—The New York City Approach
por: Misener, Mark, et al.
Publicado: (2018) -
Different mechanisms of two anti-anthrax protective antigen antibodies and function comparison between them
por: Xiong, Siping, et al.
Publicado: (2019)